Be the leaner, healthier you
Personalised Treatments, crafted just for you
Comprehensive Assessment
Our holistic approach starts with a comprehensive assessment of your health.
Evidence-Based Approach
GLP-1 evidence-based weight loss treatment.*
Ongoing Support and Monitoring
Personalised support ensures success with tailored adjustments on your journey.
What awaits on your
Weight Loss path
Explore cutting-edge treatments, crafted for
Men’s Wellness needs.
Today
Initial Assessment
Clinical Review
Prescribe GLP-1 Medication
Education and Support
1 - 6 months
Weight Loss Journey Begins
Appetite Suppression
Improved Blood Sugar Levels
Boosted Physical Activity
6 - 12 months
15% to 22% Weight Loss
Improved Metabolic Profile
Enhanced Well-Being
Embrace New Lifestyle
CUSTOMER IMPACT
Unlock your potential with evidence-based approach
Effective Weight Loss
Lose up to 22% body weight as seen in clinical trials.*
Improved Well-Being
Evidence demonstrates weight-related well-being improved after 68 weeks, including more energy and confidence.*
Healthier Heart
Over 9,000 participants in a clinical trial showed a significant increase in good cholesterol.*
Explore our
Weight Loss Treatments
TESTIMONIALS
Real Stories, Real Results:
Hear from Our Satisfied Customers
-
Damian Thorn, 32I was skeptical at first, but Priman's treatment plan exceeded my expectations. Not only did I see significant results, but the support and guidance from their team made the journey enjoyable and sustainable. Highly recommend
-
Jack Sparrow, 44Priman's approach to wellness truly changed my life. I feel more energetic, confident, and in control of my health than ever before. Thank you for providing such effective and personalised solutions
-
Jack Sparrow, 44Priman's approach to wellness truly changed my life. I feel more energetic, confident, and in control of my health than ever before. Thank you for providing such effective and personalised solutions
FAQ
Your Weight Loss Journey Questions Answered
GLP-1 receptor agonists are a class of medications that mimic the effects of a naturally occurring hormone called glucagon-like peptide-1 (GLP-1). GLP-1 plays a role in regulating blood sugar and appetite. GLP-1 receptor agonists are currently available in two primary forms: weight loss injections and weight loss tablets. We Injectable formulations have been established for some time, while a single oral GLP-1 receptor agonist has recently been approved by the FDA. Examples of injectable GLP-1 receptor agonists include liraglutide (Saxenda) and semaglutide (Ozempic). Rybelsus (semaglutide) is the first FDA-approved tablet for GLP-1 receptor agonist for weight mana
*del Olmo-Garcia, M. I. and Merino-Torres, J. F. (2018) “GLP-1 receptor agonists and cardiovascular disease in patients with type 2 diabetes,” Journal of diabetes research, 2018, pp. 1–12. doi: 10.1155/2018/4020492.
*Lapid, N. (ed.) (2023) More weight loss with Mounjaro than ozempic: Data analysis, Medscape.
*Nauck, M. A. et al. (2021) “GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art,” Molecular metabolism, 46(101102), p. 101102. doi: 10.1016/j.molmet.2020.101102.
*Marso, S. P. et al. (2016) “Liraglutide and cardiovascular outcomes in type 2 diabetes,” The New England journal of medicine, 375(4), pp. 311–322. doi: 10.1056/nejmoa1603827.